Caredx Inc buy BiotechBee
Start price
00:07
/
70%
€30.31
Target price
31.10.26
€40.00
Performance (%)
0.00%
Price
08:59
€30.31
Summary
This prediction is currently active. BiotechBee's BUY prediction for Caredx Inc is currently unchanged. This prediction currently runs until 31.10.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Caredx Inc | 0.00% |
| iShares Core DAX® | 3.054% |
| iShares Nasdaq 100 | 4.389% |
| iShares Nikkei 225® | 5.386% |
| iShares S&P 500 | 2.955% |
According to BiotechBee what are the pros and cons of Caredx Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year